bluuebunny/crossref_metadata_2025_split huggingface dataset:
Use and impact of digital technology in supporting health providers deliver care in low- and low-middle-income countries: A systematic review protocol
Authors: Craig Adam T. , Lawford Harriet , Miller Maggie , Chen-Cao Liuyi , Woods Leanna , Liaw Siaw-Teng , Godinho Myron A. 
Published: February 2025

Background
Healthcare providers are critical to the successful, sustainable and impactful implementation of digital health. Despite the growing interest, Digital Health Innovations (DHIs) are often implemented without sufficient evidence, leading to numerous short-lived projects and a limited understanding of their impact on health systems and outcomes. In 2023, the World Health Organization (WHO) introduced a new Classification of Digital Health Interventions, identifying four core DHI user groups. This review aims to synthesise evidence on the impact of DHIs designed for one of these user groups—healthcare providers—on delivering health services in low- and lower-middle-income countries (LLMICs).

Methods
We will conduct an umbrella review, analysing systematic reviews on DHIs for healthcare providers. Data will be extracted using deductive coding before being thematically analysed according to the 11 DHIs for service providers outlined in the WHO’s 2023 Classification.

Discussion
This umbrella review will explore, synthesise, and evaluate the quality of evidence on how healthcare providers in LLMICs utilise DHIs to address service delivery challenges and their effectiveness. To our knowledge, this is the first comprehensive synthesis of evidence focused on DHIs designed for use by healthcare providers in LLMICs. It is also the first review to align with WHO’s taxonomy for DHIs, as outlined in the WHO Classification of Digital Interventions, Services and Applications in Health.

Systematic review registration
The protocol is being registered in PROSPERO (ID: CRD42024586285).
Corrigendum: Adaptation of The Diabetes Distress Scale on a Russian-speaking sample of patients with type 1 and type 2 diabetes mellitus (Diabetes mellitus. – 2024. – Т. 27. – №5. https://doi.org/10.14341/DM13150)
Authors: Likhodey N. V. , Epishin V. E. , Kalashnikova M. F. , Kaurova A. M. , Tulupova M. V. , Sych Yu. P. , Bondareva I. B. 
Published: February 2025

A corrigendum on «Adaptation of The Diabetes Distress Scale on a Russian-speaking sample of patients with type 1 and type 2 diabetes mellitus» authored by Natalia V. Likhodey, Vitalii E. Epishin, Marina F. Kalashnikova, Aleksandra M. Kaurova, Margarita V. Tulupova, Yulia P. Sych, Irina B. Bondareva (2024). Diabetes Mellitus. 27(5). https://doi.org/10.14341/DM13150.An error was made in the article. In the final version of the article, the order of questions in Figure 1 and Table 4 does not correspond to the version of the questionnaire used during data collection. This discrepancy occurred because two English versions of the questionnaire, differing in the order of questions 1 and 2, were initially used in the study.The correct order of questions in The Diabetes Distress Scale is as follows:Question 1: Feeling that diabetes taking up too much of my mental and physical energy every day.Question 2: Feeling that my doctor doesn’t know enough about diabetes and diabetes careThe editorial board regrets this error. The original version of the article has been replaced.
Жанрові домінанти есею в мемуаристиці Юрія Шевельова
Authors: Zagoruyko Natalia 
Published: February 2025

У статті здійснено спробу дослідити жанрові домінанти есею в мемуаристиці Юрія Шевельова. Проаналізовано сучасні концепції жанру есею й встановлено, що завдяки синкретичності та пластичності есей стає окремою формою інтелектуального осмислення буття, породжуючи цілий пласт текстів із вираженими метажанровими ознаками. Розглядаючи стратегії есеїстичного письма, науковці наголошують на його наративно-ментативній природі та заміні ролі наратора екзогітатором. Визначено, що домінантними есеїстичними рисами мемуаристики вченого є самоідентифікація та індивідуально-авторське начало, зреалізовані через комунікативні стратегії авторефлексії, коментування та аргументації. Це дає можливість простежити етапи кристалізації національної ідентичності автора та зрозуміти мотиви його вибору. Категорія автора «створюється» в тексті самим текстом через відтворення його ставлення до навколишньої дійсності. Наративно-ментативна природа тексту спогадів, окрім звернення до стратегії коментування, для розкриття авторської позиції, реалізується завдяки асоціативним зв’язкам, суб’єктивним за природою, та відображає процес формування авторської думки «на очах у читача».Особливою рисою реалізації самоідентифікації в мемуарах Ю. Шевельова є її проєкція крізь призму пошуку «своєї території», де автор оприявнює «власну територію», шукаючи важелі самовизначення через неї. Уточнено, що «своя територія» — це не обовʼязково географічне поняття, хоча топографічні акценти неуникненні та є важливими в цій самоідентифікації. Встановлено, що концепт «своя територія» в есеїстиці вченого зреалізований через інтерпретацію англійського слова «privacy». Презентація себе через обраного носія висловлювання як жанрова ознака есею в мемуарах Ю. Шевельова здійснена за допомогою свідчень автора щодо свідомого обрання псевдонімів (Ю. Шерех, Гр. Шевчук).
Szülői bevonódás és reziliencia a roma pedagógusokat foglalkoztató iskolákban
Authors: Ceglédi Tímea 
Published: February 2025

Mi jellemzi a roma pedagógusokat foglalkoztató iskolákat, s e pedagógusok
jelenléte gazdagító erőforrás-e? Az OKM 2019. évi, telephelyi, iskolai és
tanulói (6. osztály) aggregált adatbázisát elemeztük (N = 99
615). Azonosítottuk a roma pedagógussal rendelkező iskolák tanulóit (7,7%).
Lineáris regressziót, kereszttábla-elemzést és átlagösszehasonlítást
végeztünk.
A magas roma tanulói arányú iskolákban gyakoribb a roma pedagógus
foglalkoztatása, de alacsonyabb a szülői bevonódás. A roma pedagógust
foglalkoztató iskolák nagyobb kihívásokkal néznek szembe, ugyanakkor inkább
támogatják a tanulók hátrányainak leküzdését. A roma pedagógus jelenléte fokozza
(a szülők szűkebb körét elérő) szülői bevonódás hatását a fegyelemre nézve. A
roma tanulók aránya mentén eltérő mintázatokat látunk.
Demography, clinical presentation and management of blepharoptosis at a tertiary eye care centre in western India
Authors: Agrawal Garima , Meena Seema 
Published: February 2025

: Study of blepharoptosis from western India in the recent COVID era are sparse. We undertook this study to document the demography, pathogenetic subtype, clinical presentation and management of blepharoptosis at our western regional Institute of ophthalmology.: The study was a prospective, interventional, cross-sectional study. 85 consecutive patients with blepharoptosis attending the outpatient department of our tertiary eye care centre were enrolled. All patients were subjected to a thorough history taking and examination. The patients were managed as per the pathogenetic mechanism of ptosis. The patients were examined postoperatively at day one, one week, three weeks, six weeks and three months. The outcome, sequelae and complications (if any) were documented.: The statistical analysis was done using the arithmetic mean and percentages.: The most common type of ptosis observed was congenital 78 (91.76%). The most common type of congenital ptosis was myogenic ptosis due to a dystrophic levator muscle in 43 (50.6%) of cases followed by Marcus gunn jaw winking synkinesis in 25 (29.4%) of cases. Frontalis sling was the most performed surgery. The outcome of the surgical management of blepharoptosis was good in 70 (85.36%) cases. The most common complication aka sequelae were astigmatic changes in 11 (12.94%) of cases.: The spectrum of demography, clinical presentation and management of blepharoptosis at our tertiary eye care centre in western India has been documented in the present era. The study findings complement those of other researchers. They are unique on their own with respect to the geographical area and the recent COVID-19 era.
Patient pushback: Why some resist progressive addition lenses for presbyopia
Authors: Sah Manish Kumar , Tiwari Priyanshu , Kumar Prashant , Sah Ruchika 
Published: February 2025

To identify and assess various challenges and problems that presbyopia patients have when wearing progressive lenses. This was a descriptive, cross-sectional survey. The study utilized a semi-structured questionnaire prepared specifically for the investigation. Faculty and specialists in the subject verified the questionnaire. The inclusion criteria include all presbyopia patients with normal general health, whether they are current spectacle wearers or non-spectacle users. A prepared questionnaire was used to conduct interviews with each respondent. The examiner thoroughly explained the structured questionnaire before administering it to participants. The questionnaire was divided into three sections: the respondent's demographic information, information on their present spectacles, including whether or not they used spectacles, the types of near correction, and the reasons they did not use progressive addition lenses. A total of 270 persons participated in this study, with 163 being male and 107 female. The study revealed that 43 participants, or 15.93%, used single vision glasses for near vision. Bifocals were utilized by 141 individuals, accounting for 52.22% of the total, a significant amount. Progressive addition lenses (PALs) were utilized by 52 participants, making up 19.26%. Furthermore, despite having presbyopia, 34 subjects (12.59%) did not use glasses for close vision. We found that 176 participants, or 65.19%, were aware of progressive addition lenses. In contrast, 94 participants, making up 34.81%, were not aware of progressive addition lenses. Out of the participants who did not use progressive addition lenses, 94 individuals (34.81%) cited lack of awareness about PALs as the reason. Additionally, 43 participants (15.93%) mentioned longer adaption times as a deterrent. Presbyopia patient’s impressions of progressive lenses are multidimensional, reflecting both the benefits and drawbacks of using them. According to our findings, while many patients appreciate the smooth vision correction provided by progressive lenses, a lack of awareness and initial adaptation might be significant impediments to adoption.
To study the extent of regression of retinal neovascularisation in proliferative diabetic retinopathy following laser photocoagulation of the ischaemic retina
Authors: Nazm Nazneen , Nadeem  , Mukherjee Madhura 
Published: February 2025

Eyes with proliferative diabetic retinopathy have a variable response to treatment with panretinal photocoagulation (PRP) or anti–vascular endothelial growth factor agents. We undertook this study to find out what is the exact extent of regression of neovascularisation with PRP and what are the factors that correlate with this variation in response. Present Prospective Study was conducted in Subjects with Proliferative Diabetic Retinopathy attending the ophthalmology department at ESI-PGIMSR and Model Hospital, Basaidarapur, New Delhi from October 2019-April 2021. During the above-mentioned period a total of 38 eyes of 22 patients with proliferative diabetic retinopathy were selected for the study. This study was done to evaluate the regression of neovascularisation after panretinal photocoagulation for proliferative diabetic retinopathy. In our study population, 16 (72.72%) of the subjects were males with age (mean ± SD) 60.00± 4.20 years were more than females 6 (27.27%) with age (mean ± SD) 51.56± 5.41 years. the area of neovascularisation in our patients ranged from 0.42 mm2 to 9.23 mm2 while the area of NVD in our patients ranged from 0 mm2 to 0.8 mm2 and the area of NVE in our patients at baseline ranged from 0.21 mm2 to 8.61 mm2. After 3 months of PRP all the neovascularisations showed regression to a significant extent. 31.58% of PDR eyes shows complete neovascularisation regression while 68.42% shows partial regression which is highly significant. PRP was shown to induce regression of neovascularisation and arrest of progression of diabetic retinopathy. PRP in PDR reduced the risk of severe visual loss. Timely applied laser photocoagulation of the ischaemic retina was effective in causing regression of the already developed neovascularisation and in preventing further development of neovascularisation.
Effectiveness of glaucoma diagnosis using optical coherence tomography in patients with unreliable standard automated perimetry test
Authors: Rathod Vishakha Narayan , Chikkanayakanahalli Kavitha , Sandeep K  , Acharya Pavana , Anusha K S  
Published: February 2025

: Glaucoma, a leading cause of blindness in people over 40 years old, involves progressive retinal ganglion cell loss. Early diagnosis and treatment are crucial. Visual Field (VF) testing, though essential, is subjective and variable. Optical Coherence Tomography (OCT) objectively measures Nerve fiber layer thickness, aiding early-stage detection but less effective in advanced stages. OCT’s objectivity benefits rural and less educated population where Standard Automated Perimetry (SAP) results are often unreliable.: 1) To determine the percentage of unreliable standard automated perimetry test. 2) To analyze the socio-demographic factors of patients with unreliable standard automated perimetry test. 3) To determine the percentage of the glaucoma diagnosis using OCT in patients with unreliable standard automated perimetry.: A cross-sectional observational study was conducted on 100 glaucoma suspect patients. In glaucoma suspects, age, gender, locality, education, occupation & economic status were recorded. 30-2 central fast threshold visual field was done for 2 consecutive times. On OCT percentage of optic disc cupping, RNFL thinning were calculated & analyzed in patients with unreliable SAP: Mean age group- 52 ± 7 years. 60% had unreliable SAP. 40 cases were in age 51-70years. 39 cases were from rural locality & 21 from urban. Most of them were farmers. 22 cases were illiterate. 50 cases were from lower socio-economic status. 35 cases had RNFL thinning: 60% of individuals had unreliable SAP results. Most cases of unreliable perimetry were observed in females, age group of 51-60 years, predominantly from rural areas, engaged in farming or homemaking, with low literacy levels and a lower socio-economic status. Among these individuals, 58% were diagnosed having glaucoma using OCT, highlighting the effectiveness OCT in diagnosing glaucoma in this group.
Effect of cyclopentolate on ocular biometric parameters
Authors: Pakalapati Pradeep , Haritha Thamatam 
Published: February 2025

Accurate measurement of axial length (AL), anterior chamber depth (ACD) and corneal curvature (CC) is essential for the calculation of IOL power according to different formulas. Assessing ACD is important to determine whether there is enough room for the PC-IOLs. It is evident that a shallow ACD and/or narrow angle may increase the risk of iris pigment chaffing, particularly when posterior chamber hyperopic PC-IOLs are implanted. Overestimation of ACD may result in corneal endothelial cell damage. Cyclopentolate is a synthetic antimuscarinic cycloplegic agent available in 0.5% and 1% solutions. It is widely accepted drug for patients of all ages providing excellent short-term cycloplegia. This study aims to compare the effect of cyclopentolate 1% on ocular biometric parameters – Anterior chamber depth (ACD), Lens thickness (LT) and Axial length (AL) before and after dilatation.In this observational study, 25 eyes of patients aged 45-75 years with significant cataract with nuclear sclerosis grading up to NO5NC5 C4 P4 (according to LOCS III) were included. The study was conducted for a duration of 3 months. Ocular biometric parameters ACD, LT and AL were measured using A-scan by immersion technique and compared before and after dilatation using 1% cyclopentolate and the data was analysed using paired T-test.Statistically significant difference (p value &#60; 0.05) was observed in LT and ACD, while no significant difference was noted in AL post-cycloplegia.: Cycloplegia can significantly affect the ocular biometric parameters – deeper ACD and thinner LT. These changes in ocular biometric parameters should be considered in calculating IOL power to prevent refractive surprises after cataract surgery.
C-reactive protein as a biomarker for diabetic retinopathy: Insights from a tertiary referral hospital in India
Authors: Trivedi Kinjal Y , Chavda Prakash B , Desai Neha K , Negi Puja S , Aggarwal Somesh V 
Published: February 2025

: High blood glucose levels in diabetes mellitus (DM) may damage the eyes and cause diabetic retinopathy leading to blindness. Diabetes retinopathy (DR) evolves from NPDR to PDR during the disease course. CRP and other inflammatory mediators can serve as markers for early DR identification. : To study C- reactive protein (CRP) as a potential biomarker for diabetic retinopathy and its severity in diabetic population. : An observational prospective study was performed from October 2020 to October 2022 at a tertiary care referral centre in western India. We enrolled 115 type 2 diabetics with any grade of diabetic retinopathy. Apart from thorough ophthalmological examination, CRP levels were measured using a particle-enhanced turbidimetric immunoassay. Data analysis was done using SPSS 26.0, with a p&#60;0.05 considered as significant for this study. Results CRP was positive in 15.7% subjects. There were no significant gender or age differences between CRP positive and negative groups, with an average age of 56.82 ± 9.26 years. Most patients (69.6%) had uncontrolled diabetes and used medication. High CRP was strongly linked to high FBS, PP2BS, and HbA1c. Positive CRP was linked to increased PDR rates, showing a relationship between CRP and DR severity.: CRP levels are connected to high blood sugar and HbA1c, however few diabetic retinopathy (DR) patients have higher levels. DR screening cannot be done using CRP alone. Further study with bigger samples is required to validate these results and develop other inflammatory indicators for early DR identification and treatment.
Compliance with the international and national guidelines for new normal ophthalmic practice patterns during the pandemic and post-pandemic COVID-19 era
Authors: Palani Subashree , Kumarasamy Murugan 
Published: February 2025

To assess compliance with the international and national guidelines for new normal ophthalmic practice patterns during the pandemic and post-pandemic COVID-19 era. An online questionnaire tool was used for this longitudinal observation study. It was conducted in two phases among practicing ophthalmologists in southern India. The first phase of the study, with 31 survey questions, was conducted in December 2020, and the second phase of the study, with four questions, was conducted in December 2023. Data was analysed using SPSS software, and qualitative variables were presented as numbers and percentages.: A total of 186 ophthalmologists responded to the mail with a response rate of 47%. 37% were young ophthalmologists in the age group of 30–40 years, and 78% were operating surgeons. During the pandemic era, 72% of ophthalmologists followed triage at the hospital front desk, and 34.5% followed teleophthalmology, whereas in the post-pandemic era, only 8% of them followed the triage system. Personal protective equipment was utilised efficiently by all the participants during the pandemic era, whereas in the post-pandemic era, Likert scale showed that 62% of them completely stopped wearing face masks. 86% of them followed proper instrument cleaning methodology in the outpatient department, which declined to 5% in the post-pandemic era. Triage, teleophthalmology, usage of a face mask, proper instrument sterilisation, and surgical precautions were some of the simple new normal practice patterns that can be followed in the post-pandemic period to prevent COVID and other deadly infections by health care professionals.Healthcare practitioners can prevent themselves from acquiring COVID-19 and other deadly infections such as disease 'X' in the post-pandemic period by implementing basic new normal practice patterns such as triage, teleophthalmology, face mask usage, adequate equipment sterilisation, and adhering strictly to surgical precautions protocols.
Comparision of central retinal layer thickness in patients with PDR treated with intravitreal ranibizumab vs ranibizumab plus PRP
Authors: Vivekanand Undrakonda , Eluri Chandana Priyadarsini , Kannegolla Anudeep 
Published: February 2025

Diabetic retinopathy (DR) is the primary cause of blindness in the working population worldwide and is a common consequence of type 2 diabetes (T2DM). One significant risk factor for serious vision loss in individuals with diabetes mellitus is retinal neovascularization (NV). Since the 1980s, retinal photocoagulation (PRP) has been the gold standard for treating diabetic retinopathy (DR) because it increases the availability of oxygen to the retina and reduces the subsequent release of vascular endothelial growth factors (VEGF), which prevents the progression of diabetic retinopathy. Intravitreal anti VEGF therapy show combine anti-angiogenic and anti-edematous properties and significantly altered the course of DR.The purpose of this study is to assess the central retinal thickness (CRT) of eyes from patients with proliferative diabetic retinopathy (PDR) receiving intravitreal ranibizumab versus ranibizumab with pan retinal photocoagulation (PRP).: Thirty patients with proliferative diabetic retinopathy were split into two groups for this prospective randomized control trial. Fifteen eyes in Group A received intravitreal ranibizumab, while fifteen eyes in Group B received intravitreal ranibizumab plus panretinal photocoagulation (PRP). The study was carried out over a six-month period. Using paired T tests and analysis of variance, visual acuity and central retinal thickness (CRT) were assessed at baseline, week 4, and week 8.: Best corrected visual acuity and Central Retinal thickness show a significant difference statistically (p value &#60;0.05) between the two groups. Group A had a baseline visual acuity of 0.85 ± 0.10 compared to Group B 0.98 ± 0.14 with p value 0.007. By week 8, Group A showed a visual acuity of 0.34 ± 0.07 versus 0.26 ± 0.07 in Group B with p value 0.0012. Additionally, Group A's baseline CRT was 258.33 ± 20.33 µm compared to Group B's 267.40 ± 29.40 µm (p = 0.00002), and by week 8, it measured 217.26 ± 10.49 µm versus 228.00 ± 15.69 µm (p = 0.032). Compared to intravitreal ranibizumab alone, the combination of pan retinal photocoagulation with intravitreal ranibizumab is a more successful treatment for proliferative diabetic retinopathy. Central retinal thickness, macular edema, and neovascularization are reduced more significantly with combination therapy, potentially reducing the need for injections.